Log in with your email address username.


[Correspondence] On the economics of managing blood pressure

The Lancet Commission on hypertension1 (Sept 24, p 2665) states that the cost of managing hypertension to lower cardiovascular disease risk in medium-risk or high-risk patients is less than US$1 in low-income countries, $1·50 in lower-middle-income countries, and $2·50 in upper-middle-income countries. The Commission also states that a multidrug package targeting hypertension and cardiovascular disease can be provided at $1·08 per person. These estimates are based on modelling exercises by WHO2 and Lim and colleagues.